Huons Meditech drives global growth, participating in medical device symposiums in AU&US

- hosts a launching seminar & participates in a Non-Surgical Symposium (NSS) in Australia -

▲ (Left) Huons Meditech held a ‘Dermashine Pro’ launching seminar in Kingscliff, NSW, Australia 

(Right) Huons Meditech exhibited at World Health Expo Miami, U.S.

Huons Group’s medical device subsidiary, Huons Meditech, is actively expanding its global reach by participating in overseas exhibitions and conferences.

Huons Meditech (CEO Lee Jin-suk) announced on June 16 that it had hosted a ‘Dermashine Pro’ launching seminar and participated in an aesthetic symposium.

The launching seminar was held at Peppers Salt Resort & Spa in Kingscliff, NSW, Australia on June 12. The seminar was prepared to showcase ‘Dermashine Pro’ for the first time with the Oceanian (Australia, New Zealand) distribution partner SurgeMed.

The domestic and international key opinion leaders (KOLs) who attended the seminar as speakers introduced the treatment method of ‘Dermashine Pro’ to about 200 local health care professionals (HCPs). Dr. Hosung Choi from PIENA Aesthetic Medical Clinic received a lot of attention as he explained and demonstrated ‘Dermashine Pro’ on site.

Huons Meditech participated in the Non-Surgical Symposium (NSS) held at Gold Coast, Queensland from June 13 to 15. NSS, an annually held three-day conference and now in its 14th year, is Australia’s largest symposium for non-surgical and minimally invasive cosmetic medicine. At the symposium, the company presented live demonstrations and clinical application cases of the ‘Dermashine Pro’ with local KOLs.

‘Dermashine Pro’ is an aesthetic medical device which features precise drug infusion function and user-friendly design interface. Huons Meditech has obtained a TGA (Therapeutic Goods Administration) approval on ‘Dermashine Pro’ from Australian government. With this approval, the company plans to aggressively progress into the Australian market and enter the global aesthetics market.

CEO of Huons Meditech, Lee Jin-suk said “It is meaningful that in the beginning of this year, we signed distribution contract for ‘Dermashine Pro’ in Australia and New Zealand - where Korean aesthetics are highly preferred, and successfully hosted the launching seminar. Huons Meditech will continue to actively participate in overseas exhibitions and conferences and focus on developing academic marketing tools to expand our global reach.”

Recently, Huons Meditech is strengthening its global presence while participating in international healthcare exhibitions and conferences. Huons Meditech had participated in WHX MIAMI 2025 from June 11 to 13 and showcased extracorporeal shock wave lithotriptor (ESWL) ‘ASADAL-M1’ and automatic mesotherapy injector ‘Dermashine Pro’ at the exhibition booth. According to a company official, Huons Meditech introduced the competitive advantages of the products and attracted much attention from visitors.